Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Zajicek

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Handbook of Clinical Neurology|January 15, 2013
Multiple sclerosisJohn Zajicek
Expert Opinion on Investigational Drugs|July 19, 2005
The use of cannabinoids in multiple sclerosisLara Teare, John Zajicek
Clinical Medicine (London, England)|July 13, 2012
Analysis and validation of a Parkinson's disease register as a recruitment tool for clinical studiesCamille Carroll, Amy Palmer, Christine Cosby, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2015
Lending a hand: can DASH items help ABILHAND improve manual ability measurement in multiple sclerosis?Louise Barrett, Stefan Cano, John Zajicek, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 24, 2014
Using 'dead or dependent' as an outcome measure in clinical trials in Parkinson's diseaseDavid McGhee, Alexander Parker, Shona Fielding, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2012
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6DAnnie Hawton, Colin Green, Claire Telford, et al.
Brain Pathology (Zurich, Switzerland)|January 22, 2011
Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosisHua Zhang, David A Hilton, C Oliver Hanemann, et al.
Journal of Neurology|January 23, 2010
The epidemiology of motor neurone disease in two counties in the southwest of EnglandIbrahim Imam, Susan Ball, Dave Wright, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 27, 2013
Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measuresJennifer Freeman, Richard Walters, Wendy Ingram, et al.
Journal of Neuroscience Methods|April 26, 2005
Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasksXuguang Liu, Camille B Carroll, Shou-Yan Wang, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Handbook of Clinical Neurology|January 15, 2013
Multiple sclerosisJohn Zajicek
Expert Opinion on Investigational Drugs|July 19, 2005
The use of cannabinoids in multiple sclerosisLara Teare, John Zajicek
Clinical Medicine (London, England)|July 13, 2012
Analysis and validation of a Parkinson's disease register as a recruitment tool for clinical studiesCamille Carroll, Amy Palmer, Christine Cosby, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2015
Lending a hand: can DASH items help ABILHAND improve manual ability measurement in multiple sclerosis?Louise Barrett, Stefan Cano, John Zajicek, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 24, 2014
Using 'dead or dependent' as an outcome measure in clinical trials in Parkinson's diseaseDavid McGhee, Alexander Parker, Shona Fielding, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2012
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6DAnnie Hawton, Colin Green, Claire Telford, et al.
Brain Pathology (Zurich, Switzerland)|January 22, 2011
Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosisHua Zhang, David A Hilton, C Oliver Hanemann, et al.
Journal of Neurology|January 23, 2010
The epidemiology of motor neurone disease in two counties in the southwest of EnglandIbrahim Imam, Susan Ball, Dave Wright, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 27, 2013
Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measuresJennifer Freeman, Richard Walters, Wendy Ingram, et al.
Journal of Neuroscience Methods|April 26, 2005
Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasksXuguang Liu, Camille B Carroll, Shou-Yan Wang, et al.
Pageof 3